Bruton's tyrosine kinase inhibition - An emerging therapeutic strategy in immune-mediated dermatological conditions

MLA

Mendes-Bastos, Pedro, et al. Bruton’s Tyrosine Kinase Inhibition - An Emerging Therapeutic Strategy in Immune-Mediated Dermatological Conditions. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0c88b1e0efdbf51ce87c92c49ef04f89&authtype=sso&custid=ns315887.

APA

Mendes-Bastos, P., Brasileiro, A., Kolkhir, P., Frischbutter, S., Scheffel, J., Moñino-Romero, S., & Maurer, M. (2022). Bruton’s tyrosine kinase inhibition - An emerging therapeutic strategy in immune-mediated dermatological conditions.

Chicago

Mendes-Bastos, Pedro, Ana Brasileiro, Pavel Kolkhir, Stefan Frischbutter, Jörg Scheffel, Sherezade Moñino-Romero, and Marcus Maurer. 2022. “Bruton’s Tyrosine Kinase Inhibition - An Emerging Therapeutic Strategy in Immune-Mediated Dermatological Conditions,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0c88b1e0efdbf51ce87c92c49ef04f89&authtype=sso&custid=ns315887.